R. Mosher

NaPi2b expression in a large surgical Non-Small Cell Lung Cancer (NSCLC) cohort

F. Hirsch, S. Heynemann, Hongfeng Yu, 2021, Clinical Lung Cancer.

Papillary immature metaplasia (immature condyloma) of the cervix: a clinicopathologic analysis and comparison with papillary squamous carcinoma.

C. Crum, E. Sheets, P. Trivijitsilp, 1998, Human pathology.

Cytologic correlates of papillary immature metaplasia (immature condyloma) of the cervix

C. Crum, Kenneth R. Lee, P. Trivijitsilp, 1998, Diagnostic cytopathology.

Complete hydatidiform mole. Comparison of clinicopathologic features, current and past.

R. Berkowitz, D. Genest, D. Goldstein, 1998, The Journal of reproductive medicine.

Abstract 1738: XMT-2056, a well-tolerated, Immunosynthen-based STING-agonist antibody-drug conjugate which induces anti-tumor immune activity

Jeremy R. Duvall, M. Protopopova, S. Collins, 2021, Immunology.

184 UPLIFT (ENGOT-ov67/GOG-3048) a pivotal cohort of upifitamab rilsodotin, a NaPi2b-directed ADC in platinum-resistant ovarian cancer

I. Ray-Coquard, N. Concin, L. Mileshkin, 2021, Ovarian cancer.

3P NaPi2b expression in high grade serous ovarian cancer: Results from combined data sets

B. Monk, I. Ray-Coquard, N. Concin, 2023, ESMO Open.

Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody–Drug Conjugate for the Treatment of Cancer

Jeremy R. Duvall, S. Collins, Phonphimon Wongthida, 2023, Molecular cancer therapeutics.